Current Treatment Options in Third-line MCL
Experts on mantle cell lymphoma discuss third-line treatment options available for patients.
Source: onclive.com
Cart Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cart Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cart Cells Today - Breaking & Trending Today
Dr Ann LaCasce: T-Cell Engagers Have Improved DLBCL Outcomes, but Questions on Optimal Use Remain
Ann LaCasce, MD, MMSc, director of the Dana-Farber/Mass General Brigham fellowship in hematology/oncology and chair of the Lymphoma Research Foundation’s Scientific Advisory Board, discusses T-cell engager therapies in the diffuse large B-cell lymphoma (DLBCL) landscape.
Source: ajmc.com
Is Genome Editing the Next Step in Immunotherapy Innovation? Experts Think So
Presenters at the American Society of Hematology Annual Meeting and Exposition agreed that novel strategies, such as CRISPR and base editing, have potential to fine-tune the latest immunotherapy advancements to increase the efficacy and durability of a range of treatments.
Source: ajmc.com
Seeking A Solution: Probiotic-Guided CAR T Cells For Solid Tumors
Beyond yogurt ads and health supplements, probiotics could revitalize cell-based cancer immunotherapies such as CAR T therapy.
Source: forbes.com
'Theory of all matter' physicists among 2023 Breakthrough prize winners | Science prizes
Immunologists behind pioneering cancer therapy also among recipients of most lucrative prize in science
Source: theguardian.com